Phosphoproteomic characterization of the signaling network resulting from activation of the chemokine receptor CCR2
Open Access
- 8 May 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 295 (19), 6518-6531
- https://doi.org/10.1074/jbc.RA119.012026
Abstract
No abstract availableFunding Information
- Department of Health | National Health and Medical Research Council (APP1140874)
- Monash Institute of Pharmaceutical Sciences (Large Grant Support Scheme)
- Monash University (JMP16–18)
- National Collaborative Research Infrastructure Strategy
- Bioplatforms Australia
This publication has 61 references indexed in Scilit:
- Chemokine receptor expression on monocytes from healthy individualsClinical Immunology, 2015
- Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter RegionThe American Journal of Cardiology, 2011
- Chemokines: multiple levels of leukocyte migration control☆Trends in Immunology, 2004
- Chemokine receptors: multifaceted therapeutic targetsNature Reviews Immunology, 2002
- Chemokines in pathology and medicineJournal of Internal Medicine, 2001
- Chemokines and diseaseNature Immunology, 2001
- MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein BJCI Insight, 1999
- Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient miceAtherosclerosis, 1999
- Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosisNature, 1998
- Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient MiceMolecular Cell, 1998